Karapantzou, Chrisanthi

[["dc.bibliographiccitation.firstpage","253"],["dc.bibliographiccitation.issue","2"],["dc.bibliographiccitation.journal","Journal of Neural Transmission"],["dc.bibliographiccitation.lastpage","257"],["dc.bibliographiccitation.volume","124"],["dc.contributor.author","Dressler, Dirk"],["dc.contributor.author","Karapantzou, Chrisanthi"],["dc.contributor.author","Rohrbach, Saskia"],["dc.contributor.author","Schneider, Simon"],["dc.contributor.author","Laskawi, Rainer"],["dc.date.accessioned","2020-12-10T14:10:54Z"],["dc.date.available","2020-12-10T14:10:54Z"],["dc.date.issued","2016"],["dc.identifier.doi","10.1007/s00702-016-1641-3"],["dc.identifier.eissn","1435-1463"],["dc.identifier.issn","0300-9564"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/70916"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-354"],["dc.title","Frontalis suspension surgery to treat patients with blepharospasm and eyelid opening apraxia: long-term results"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","452"],["dc.bibliographiccitation.issue","5"],["dc.bibliographiccitation.journal","HNO"],["dc.bibliographiccitation.lastpage","458"],["dc.bibliographiccitation.volume","58"],["dc.contributor.author","Matthes, Philipp"],["dc.contributor.author","Kruegel, Jenny"],["dc.contributor.author","Karapantzou, Chrisanthi"],["dc.contributor.author","Winterhoff, Jan"],["dc.contributor.author","Laskawi, Rainer"],["dc.date.accessioned","2018-11-07T08:43:33Z"],["dc.date.available","2018-11-07T08:43:33Z"],["dc.date.issued","2010"],["dc.description.abstract","There are no regional data about the prevalence and use of botulinum toxin (BoNT) in otorhinolaryngology (ORL) departments in Germany. In order to obtain an overview of the current applications of BoNT in ORL departments a survey was carried out. Standardized multi-choice questionnaires were mailed to 150 ORL departments. In the analysis a differentiation was made between university and regional departments. Also an analysis of the whole collective of respondent hospitals was carried out. The most commonly treated indication is the Frey syndrome followed by hypersalivation due to a salivary fistula after parotidectomy, dysphagia, aesthetic application and laryngeal dystonia. The rate of return was 62% and 75% of all responding hospitals use BoNT as a therapeutic option, especially where \"off-label-use\" indications are concerned (15 out of 20 indications or 75%). BoNT is widely used as a therapeutic option with an increasing trend. Due to different applications a schedule of hospitals would be helpful in order to be able to find the nearest hospital for the appropriate indications."],["dc.identifier.doi","10.1007/s00106-009-2056-3"],["dc.identifier.isi","000277427800007"],["dc.identifier.pmid","20454883"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/19998"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Springer"],["dc.relation.issn","0017-6192"],["dc.title","Use of botulinum toxin in ORL departments in Germany"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.artnumber","44"],["dc.bibliographiccitation.journal","Head & Face Medicine"],["dc.bibliographiccitation.volume","10"],["dc.contributor.author","Karapantzou, Chrisanthi"],["dc.contributor.author","Dressler, Dirk"],["dc.contributor.author","Rohrbach, Saskia"],["dc.contributor.author","Laskawi, Rainer"],["dc.date.accessioned","2018-11-07T09:33:27Z"],["dc.date.available","2018-11-07T09:33:27Z"],["dc.date.issued","2014"],["dc.description.abstract","Introduction: We describe the results of 15 patients suffering from essential blepharospasm with apraxia of eyelid opening who underwent frontalis suspension surgery. Material and methods: Patients with apraxia of eyelid opening and unresponsive to botulinum toxin injections were studied. Bilateral frontalis suspension surgery was performed (sling operation) using polytetrafluoroethylene (Gore-Tex (R)) sutures. The patients reported the degree of improvement using a subjective rating scale to evaluate the benefit of the operation at two times after surgery (0-10 days and 180-360 days). Results: The patients reported a high degree of subjective improvement. In the early postoperative period (0-10 days) the mean degree of subjective improvement was 74.6% (standard deviation (SD) 26.4%). At 180-360 days after surgery the mean improvement was 70.0% (SD 26.7%). Small hematomas of the upper lid occurred postoperatively in all patients. Other complications were suture extrusions (9.1%), suture granulomas (6.1%), lacrimation (5.0%) and local infections (7.5%). Postoperatively, all patients needed additional botulinum toxin injections for optimal outcome. Conclusion: Frontalis suspension surgery is a minimally invasive and effective treatment option for apraxia of eyelid opening in patients with essential blepharospasm unresponsive to botulinum toxin injections alone."],["dc.identifier.doi","10.1186/1746-160X-10-44"],["dc.identifier.isi","000344708200001"],["dc.identifier.pmid","25338619"],["dc.identifier.purl","https://resolver.sub.uni-goettingen.de/purl?gs-1/11008"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/31967"],["dc.notes.intern","Merged from goescholar"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Biomed Central Ltd"],["dc.relation.issn","1746-160X"],["dc.rights","CC BY 4.0"],["dc.rights.uri","https://creativecommons.org/licenses/by/4.0"],["dc.title","Frontalis suspension surgery to treat patients with essential blepharospasm and apraxia of eyelid opening-technique and results"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]